Redhill Biopharma
RDHL
#9732
Rank
HK$80.14 M
Marketcap
HK$62.59
Share price
-1.23%
Change (1 day)
4.36%
Change (1 year)

Earnings for Redhill Biopharma (RDHL)

Earnings in 2023 (TTM): HK$90.96 Million

According to Redhill Biopharma's latest financial reports the company's current earnings are HK$35.74 Million. In 2022 the company made an earning of -HK$0.56 Billion, an increase over its 2021 earnings that were of -HK$0.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Redhill Biopharma from 2012 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) HK$90.96 M-116.32%
2022 -HK$0.56 Billion-26.68%
2021 -HK$0.76 Billion28.32%
2020 -HK$0.6 Billion80.06%
2019 -HK$0.33 Billion8.97%
2018 -HK$0.31 Billion-14.76%
2017 -HK$0.36 Billion55.07%
2016 -HK$0.23 Billion39.26%
2015 -HK$0.17 Billion96.9%
2014 -HK$83.29 Million0.78%
2013 -HK$82.64 Million16.93%
2012 -HK$70.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$57.59 B 63,915.21%๐Ÿ‡ซ๐Ÿ‡ท France
HK$128.21 B 142,399.14%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$32.42 B 35,942.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$0.33 B 277.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
HK$6.43 B 7,046.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel